SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Long Term Debt Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual long term debt in 2023 was 69.19 Million EUR , down -3.14% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly long term debt in 2024 Q2 was 67.77 Million EUR , down 0.0% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported annual long term debt of 71.43 Million EUR in 2022, up 3129.34% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported annual long term debt of 2.21 Million EUR in 2021, down -34.59% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported quarterly long term debt of 67.77 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported quarterly long term debt of -91.91 Million EUR for 2024 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Long Term Debt of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 69.19 Million EUR -3.14%
2022 71.43 Million EUR 3129.34%
2021 2.21 Million EUR -34.59%
2020 3.38 Million EUR 0.0%

Peer Long Term Debt Comparison of SCHOTT Pharma AG & Co. KGaA

Name Long Term Debt Long Term Debt Difference
Carl Zeiss Meditec AG 133.88 Million EUR 48.317%
Fielmann Aktiengesellschaft 6.95 Million EUR -894.867%
Gerresheimer AG 658.49 Million EUR 89.492%
Sartorius Aktiengesellschaft 5.02 Billion EUR 98.623%
Sartorius Aktiengesellschaft 5.02 Billion EUR 98.623%